Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 386
Summary
- Conditions
- Anticoagulant Adverse Reaction
- Benign Prostatic Hyperplasia
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
SOAP is a non-inferiority, multicentric, open-labelled, two parallel arms study. The expected benefits are to foster and make the perioperative management of OAC safer in patients undergoing BPH surgery with PVP.
SOAP is a non-inferiority, multicentric, open-labelled, two parallel arms study. The expected benefits are to foster and make the perioperative management of OAC safer in patients undergoing BPH surgery with PVP.
Tracking Information
- NCT #
- NCT03297281
- Collaborators
- Boston Scientific Corporation
- Capionis
- Investigators
- Principal Investigator: Vincent Misrai, Dr Clinique Pasteur